{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:54:25Z","timestamp":1785200065572,"version":"3.55.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012670","name":"Dysimmune Diseases Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.autrev.2023.103444","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T02:16:35Z","timestamp":1693880195000},"page":"103444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype"],"prefix":"10.1016","volume":"22","author":[{"given":"A. Razzaque","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikole","family":"Kalesinskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kooper-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.135.5.569","article-title":"Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen","volume":"135","author":"Chan","year":"1999","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0010","article-title":"Anti-laminin \u03b31 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin \u03b31, type XVII collagen and laminin-332","volume":"25","author":"Akasaka","year":"2015","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0015","article-title":"Bullous pemphigoid with igg autoantibodies to the \u03b13 subunit of laminin 332 associated with psoriasis vulgaris","volume":"27","author":"Ohashi","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.13706","article-title":"Non-paraneoplastic autoimmune subepidermal bullous disease associated with fatal bronchiolitis obliterans","volume":"44","author":"Orime","year":"2017","journal-title":"J Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103444_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.13977","article-title":"Anti-laminin-332-type mucous membrane pemphigoid in a patient with adult T-cell leukemia\/lymphoma and graft-versus-host disease","volume":"44","author":"Baba","year":"2017","journal-title":"J Dermatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103444_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.16008","article-title":"Case of pemphigoid with antibodies to BP180 C-terminal domain and \u03b13 subunit of laminin-332 associated with chronic graft-versus-host disease","volume":"48","author":"Kawashima","year":"2021","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000243807","article-title":"Mucous membrane pemphigoid with antibodies to the beta(3) subunit of Laminin 332 in a patient with acute myeloblastic leukemia and graft-versus-host disease","volume":"219","author":"Takahara","year":"2009","journal-title":"Dermatology"},{"issue":"5 SUPPL","key":"10.1016\/j.autrev.2023.103444_bb0040","article-title":"Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease","volume":"56","author":"Izumi","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103444_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.15365","article-title":"Subepidermal blistering disease acquired autoantibody against laminin 332 during treatment for bullous pemphigoid","volume":"47","author":"Mashima","year":"2020","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2018.5536","article-title":"Overlap of Bullous, Anti-Laminin-332, and Anti-p200 Pemphigoid with concomitant Anti-Contactin-1-Positive inflammatory polyneuropathy treated with intravenous immunoglobulins as a manifestation of epitope spreading","volume":"155","author":"Wald","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2023.103444_bb0055","article-title":"Epidermolysis bullosa acquisita with concomitant autoantibodies to \u03b13 subunit of laminin 332","author":"Hamaguchi","year":"2022","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.14169","article-title":"Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies","volume":"45","author":"Nishida","year":"2018","journal-title":"J Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103444_bb0065","article-title":"A case of subepidermal blistering disease with autoantibodies to multiple laminin subunits who developed later autoantibodies to alpha-5 chain of type IV collagen associated with membranous glomerulonephropathy","volume":"95","author":"Sueki","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane Pemphigoid","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cden.2013.07.003","article-title":"Mucous membrane pemphigoid","volume":"57","author":"Xu","year":"2013","journal-title":"Dent Clin N Am"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103036","article-title":"Mucous membrane pemphigoid","volume":"21","author":"Du","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.md.0000076003.64510.00","article-title":"Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations","volume":"82","author":"Egan","year":"2003","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.autrev.2023.103444_bb0090","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1346-8138.2010.01185.x","article-title":"Mucous membrane pemphigoid with antibodies to the \u03b23 subunit of laminin 332","volume":"38","author":"Masunaga","year":"2011","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0095","first-page":"105","article-title":"Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid","volume":"29","author":"Maki","year":"2021","journal-title":"Acta Dermatovenerol Croat"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.2009.09508.x","article-title":"Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid","volume":"162","author":"Natsuga","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2340\/00015555-0506","article-title":"Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy","volume":"88","author":"Fukushima","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103444_bb0110","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archderm.1993.01680280058011","article-title":"A paraneoplastic mixed bullous skin disease associated with anti-skin antibodies and a B-cell lymphoma","volume":"129","author":"Bystryn","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2023.103444_bb0115","first-page":"685","article-title":"Cicatricial pemphigoid associated with lung tumor","volume":"54","author":"Abe","year":"2000","journal-title":"Jpn J Clin Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.autrev.2023.103444_bb0120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0190-9622(97)80237-X","article-title":"Anti-epiligrin cicatricial pemphigoid in a patient with HIV","volume":"36","author":"Lish","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1684\/ejd.2015.2622","article-title":"Development of mucous membrane pemphigoid with antibodies to the \u03b23 subunit of laminin 332 and bronchiolitis obliterans in a patient with chronic graft-versus-host disease","volume":"25","author":"Okada","year":"2015","journal-title":"Eur J Dermatol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103444_bb0130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1445-5994.2003.t01-1-00430.x","article-title":"Cicatricial pemphigoid in non-Hodgkin\u2019s lymphoma","volume":"33","author":"Shannon","year":"2003","journal-title":"Intern Med J"},{"issue":"JAN","key":"10.1016\/j.autrev.2023.103444_bb0135","article-title":"Severe refractory paraneoplastic mucous membrane pemphigoid successfully treated with rituximab","volume":"6","author":"Wittenberg","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103444_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220887","article-title":"Paraneoplastic mucous membrane pemphigoid with ocular and laryngeal involvement","volume":"2017","author":"Lambiel","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0145","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2133.1999.02773.x","article-title":"Antiepiligrin (Laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5","volume":"140","author":"Taniuchi","year":"1999","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0150","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2133.1999.02933.x","article-title":"Paraneoplastic cicatricial pemphigoid","volume":"141","author":"Setterfield","year":"1999","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2011.10520.x","article-title":"A case of paraneoplastic pemphigus associated with triple malignancies in combination with antilaminin-332 mucous membrane pemphigoid","volume":"166","author":"Yamada","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0160","article-title":"Anti-laminin-332 mucous membrane pemphigoid associated with recurrent metastatic prostate carcinoma: Hypothesis for a paraneoplastic phenomenon","volume":"21","author":"Young","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0165","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1365-2133.2008.08483.x","article-title":"Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features","volume":"158","author":"Mitsuya","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-0960.2004.00068.x","article-title":"Paraneoplastic immunobullous disease with an epidermolysis bullosa acquisita phenotype: two cases demonstrating remission with treatment of gynaecological malignancy","volume":"45","author":"Chamberlain","year":"2004","journal-title":"Austral J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/00003226-200007000-00033","article-title":"Remission of antiepiligrin (Laminin-5) cicatricial pemphigoid after excision of gastric carcinoma","volume":"19","author":"Uchiyama","year":"2000","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.autrev.2023.103444_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12348","article-title":"Remission of anti-epiligrin cicatricial pemphigoid after excision of cervical adenocarcinoma","volume":"41","author":"Ding","year":"2014","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0185","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2133.1997.19522044.x","article-title":"Anti-epiligrin (laminin 5) cicatricial pemphigoid and lung carcinoma: coincidence or association?","volume":"137","author":"Gibson","year":"1997","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/j.1346-8138.2004.tb00497.x","article-title":"A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy","volume":"31","author":"Matsushima","year":"2004","journal-title":"J Dermatol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103444_bb0195","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1111\/j.1365-2230.2009.03646.x","article-title":"A case of mucous membrane pemphigoid with IgG antibodies against all the alpha3, beta3 and gamma2 subunits of laminin-332 and BP180 C-terminal domain, associated with pancreatic cancer","volume":"34","author":"Demitsu","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2023.103444_bb0200","article-title":"Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita","volume":"139","author":"Fujimoto","year":"1998","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/j.1346-8138.2012.01645.x","article-title":"Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to \u03b13, \u03b23 and \u03b32 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site","volume":"40","author":"Fukuchi","year":"2013","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0210","article-title":"Cicatricial pemphigoid with autoantibodies to laminin 5 (epiligrin) in a patient with metastatic endometrial carcinoma","volume":"49","author":"Lenz","year":"1998","journal-title":"Hautarzt"},{"issue":"10","key":"10.1016\/j.autrev.2023.103444_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/j.1346-8138.2011.01482.x","article-title":"Mucous membrane pemphigoid accompanied by ovarian cancer: A case with autoantibodies solely against \u03b32-subunit of laminin-332","volume":"39","author":"Shibuya","year":"2012","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000243807","article-title":"Mucous membrane pemphigoid with antibodies to the beta(3) subunit of Laminin 332 in a patient with acute myeloblastic leukemia and graft-versus-host disease","volume":"219","author":"Takahara","year":"2009","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2009.09.013","article-title":"Mucous membrane pemphigoid with autoantibodies to all the laminin 332 subunits and fatal outcome resulting from liver cirrhosis and hepatocellular carcinoma","volume":"64","author":"Dainichi","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"10.1016\/j.autrev.2023.103444_bb0230","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3621","article-title":"Remission of anti-laminin 332 mucous membrane pemphigoid associated with non-small cell lung cancer after therapy with rituximab and intravenous immunoglobulin","volume":"100","author":"Tarnowietzki","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.02.012","article-title":"A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer","volume":"47","author":"Sadler","year":"2007","journal-title":"J Dermatol Sci"},{"issue":"9","key":"10.1016\/j.autrev.2023.103444_bb0240","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2023.103444_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.771766","article-title":"The second study of clinical and immunological findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid examined at Kurume University\u2014diagnosis criteria suggested by summary of 133 cases","volume":"12","author":"Qian","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0250","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2011.10474.x","article-title":"Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients","volume":"165","author":"Terra","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0255","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.oooo.2013.12.402","article-title":"Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing","volume":"117","author":"Hayakawa","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2009.02.012","article-title":"Histopathology of anti-laminin 5 mucous membrane pemphigoid","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0265","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1684\/ejd.2020.3765","article-title":"Diagnosis of autoimmune subepidermal bullous diseases with mucous membrane involvement based on laser-scanning confocal microscopy","volume":"30","author":"Wozniak","year":"2020","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2023.103444_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2019.09.026","article-title":"Laminin 332 in cancer: When the extracellular matrix turns signals from cell anchorage to cell movement","volume":"62","author":"Rousselle","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02648-y","article-title":"Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea","volume":"23","author":"Han","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103444_bb0280","article-title":"Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0285","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2020.0024","article-title":"Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"156","author":"Vaengebjerg","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103444_bb0290","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2019.3056","article-title":"Association of Psoriasis with the risk of developing or dying of cancer","volume":"155","author":"Trafford","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2017.05.006","article-title":"Association of bullous pemphigoid with malignancy: a systematic review and meta-analysis","volume":"77","author":"Atzmony","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0300","article-title":"Bullous pemphigoid and internal diseases - a case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0305","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2021.5125","article-title":"Risk of all-cause mortality, cardiovascular disease mortality, and cancer mortality in patients with Bullous Pemphigoid","volume":"158","author":"Shen","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ijc.31025","article-title":"Cancer risk of Lichen planus: A cohort study of 13,100 women in Finland","volume":"142","author":"Halonen","year":"2018","journal-title":"Int J Cancer"},{"issue":"17","key":"10.1016\/j.autrev.2023.103444_bb0315","doi-asserted-by":"crossref","first-page":"adv00303","DOI":"10.2340\/00015555-3664","article-title":"Incidence of Lichen planus and subsequent mortality in finnish women","volume":"100","author":"Halonen","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"14","key":"10.1016\/j.autrev.2023.103444_bb0320","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jama.1980.03300400045031","article-title":"Epidermolysis bullosa acquisita. Association with amyloidosis and multiple myeloma","volume":"243","author":"Trump","year":"1980","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0325","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2133.2005.06466.x","article-title":"Squamous cell carcinoma arising on scars of epidermolysis bullosa acquisita","volume":"152","author":"Yamada","year":"2005","journal-title":"Br J Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.autrev.2023.103444_bb0330","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0190-9622(87)80296-7","article-title":"Epidermolysis bullosa acquisita associated with lymphoma","volume":"17","author":"Baler","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0335","doi-asserted-by":"crossref","DOI":"10.1067\/mjd.2002.113682","article-title":"Epidermolysis bullosa acquisita and multiple myeloma","volume":"47","author":"Engineer","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0340","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2230.1985.tb00546.x","article-title":"Epidermolysis bullosa acquisita associated with chronic lymphatic leukaemia","volume":"10","author":"Shaw","year":"1985","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0345","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2340\/00015555-2219","article-title":"Paraneoplastic epidermolysis Bullosa acquisita associated with Thyroid Carcinoma","volume":"96","author":"Lombardo","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2230.1985.tb00546.x","article-title":"Epidermolysis bullosa acquisita associated with chronic lymphatic leukaemia","volume":"10","author":"Shaw","year":"1985","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0355","doi-asserted-by":"crossref","DOI":"10.1111\/j.1754-4505.2006.tb01718.x","article-title":"Paraneoplastic epidermolysis bullosa acquisita associated with multiple myeloma","volume":"26","author":"Radfar","year":"2006","journal-title":"Spec Care Dentist"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0360","first-page":"E13","article-title":"Epidermolysis bullosa acquisita in association with mantle cell lymphoma","volume":"101","author":"Shaffer","year":"2018","journal-title":"Cutis"},{"issue":"10","key":"10.1016\/j.autrev.2023.103444_bb0365","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1610-0387.2007.06338.x","article-title":"Epidermolysis bullosa acquisita and neuroendocrine pancreatic cancer - Coincidence or patho-genetic relationship?","volume":"5","author":"Busch","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"10.1016\/j.autrev.2023.103444_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ki.5001790","article-title":"Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association","volume":"70","author":"Lefaucheur","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0375","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2007.06.003","article-title":"Long-term risk of cancer in membranous Nephropathy patients","volume":"50","author":"Bj\u00f8rneklett","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.03.011","article-title":"Malignancy and rheumatoid arthritis: epidemiology, risk factors and management","volume":"32","author":"De Cock","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103444_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101806","article-title":"Cancer risk in patients with primary immune thrombocytopenia \u2013 a Swedish nationwide register study","volume":"69","author":"Ekstrand","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.autrev.2023.103444_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2018.12.014","article-title":"Multiple sclerosis and cancer incidence: a Danish nationwide cohort study","volume":"28","author":"N\u00f8rgaard","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0395","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0400","doi-asserted-by":"crossref","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis: a systematic review and meta-analysis","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0405","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-022-08944-y","article-title":"Autoantibodies and cancer association: the case of systemic sclerosis and dermatomyositis","volume":"63","author":"Fiorentino","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"JAN","key":"10.1016\/j.autrev.2023.103444_bb0410","article-title":"Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors","volume":"10","author":"Maria","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0415","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatol (U K)"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2007.08.006","article-title":"Cancer in Rheumatoid Arthritis: occurrence, mortality, and associated factors in a south european population","volume":"37","author":"Ab\u00e1solo","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0425","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjh.12869","article-title":"Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study","volume":"166","author":"Frederiksen","year":"2014","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0430","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011219","article-title":"Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study","volume":"96","author":"Marrie","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study","volume":"165","author":"Kuo","year":"2011","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103444_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/acr.24076","article-title":"Incidence, risk factors, and outcomes of cancer in systemic sclerosis","volume":"72","author":"Morrisroe","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis","volume":"21","author":"Zhong","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2023.103444_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.matbio.2009.07.008","article-title":"Defining the role of laminin-332 in carcinoma","volume":"28","author":"Guess","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2023.103444_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2016.07.021","article-title":"Autoimmunity against laminins","volume":"170","author":"Florea","year":"2016","journal-title":"Clin Immunol"},{"issue":"35","key":"10.1016\/j.autrev.2023.103444_bb0460","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M100798200","article-title":"The LG3 module of Laminin-5 Harbors a binding site for integrin \u03b13\u03b21 that promotes cell adhesion, spreading, and migration","volume":"276","author":"Shang","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0465","doi-asserted-by":"crossref","DOI":"10.1093\/jb\/mvi153","article-title":"Regulation of cell adhesion and type VII collagen binding by the \u03b23 chain short arm of laminin-5: effect of its proteolytic cleavage","volume":"138","author":"Nakashima","year":"2005","journal-title":"J Biochem"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0470","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1083\/jcb.153.4.835","article-title":"The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion","volume":"153","author":"Gagnoux-Palacios","year":"2001","journal-title":"J Cell Biol"},{"issue":"18","key":"10.1016\/j.autrev.2023.103444_bb0475","article-title":"Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon Adenocarcinomas","volume":"55","author":"Pyke","year":"1995","journal-title":"Cancer Res"},{"issue":"11\u201312","key":"10.1016\/j.autrev.2023.103444_bb0480","article-title":"Biological function of laminin-5 and pathogenic impact of its deficiency","volume":"86","author":"Schneider","year":"2007","journal-title":"Eur J Cell Biol"},{"issue":"15","key":"10.1016\/j.autrev.2023.103444_bb0485","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M413051200","article-title":"Regulation of biological activity and matrix assembly of laminin-5 by COOH-terminal, LG4-5 domain of \u03b13 chain","volume":"280","author":"Tsubota","year":"2005","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6604252","article-title":"Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation","volume":"98","author":"Baba","year":"2008","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.02.005","article-title":"Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy","volume":"18","author":"Buonavoglia","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0500","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","article-title":"Cicatricial pemphigoid","volume":"25","author":"Ahmed","year":"1986","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0505","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2008.02.035","article-title":"IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid","volume":"58","author":"Lazarova","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.clindermatol.2013.11.003","article-title":"Autoimmune blistering dermatoses as systemic diseases","volume":"32","author":"Vassileva","year":"2014","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0520","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0855-x","article-title":"Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid","volume":"13","author":"Chiorean","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"10.1016\/j.autrev.2023.103444_bb0525","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology \u2013 Part I","volume":"35","author":"Rashid","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0530","article-title":"Treatment strategies in mucous membrane pemphigoid","volume":"4","author":"Neff","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.autrev.2023.103444_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/S0300-483X(02)00612-1","article-title":"Immunosuppressive drugs and cancer","author":"Vial","year":"2003","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0540","doi-asserted-by":"crossref","DOI":"10.1111\/j.1349-7006.2006.00150.x","article-title":"Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion","volume":"97","author":"Miyazaki","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.autrev.2023.103444_bb0545","article-title":"Wide distribution of laminin-5 \u03b32 chain in basement membranes of various human tissues","author":"Mizushima","year":"1998","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0550","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.jbchem.a021541","article-title":"Differential expression of laminin-5\/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors","volume":"120","author":"Mizushima","year":"1996","journal-title":"J Biochem"},{"key":"10.1016\/j.autrev.2023.103444_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.807173","article-title":"Molecular basis for global incidence of pemphigoid diseases and differences in phenotypes","volume":"13","author":"Ahmed","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103444_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2017.07.022","article-title":"Cancer and autoimmune diseases","volume":"16","author":"Giat","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2023.103444_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102882","article-title":"Autoimmunity and cancer","volume":"20","author":"Masetti","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103041","article-title":"Tumour- associated autoantibodies as prognostic cancer biomarkers- a review","volume":"21","author":"Sexauer","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.01.017","article-title":"Autoantibody production in cancer-the humoral immune response toward autologous antigens in cancer patients","volume":"15","author":"Zaenker","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2023.103444_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2017.10.012","article-title":"The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours","volume":"16","author":"Wu","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0585","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000222","article-title":"Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening","volume":"27","author":"Shah","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103444_bb0590","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-\u03b3 antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0595","doi-asserted-by":"crossref","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"18","key":"10.1016\/j.autrev.2023.103444_bb0600","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.15613","article-title":"Investigation of three potential autoantibodies in Sjogren\u2019s syndrome and associated MALT lymphoma","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0605","doi-asserted-by":"crossref","DOI":"10.1111\/j.1348-0421.2010.00215.x","article-title":"Proteomic surveillance of autoantigens in patients with behcet\u2019s disease by a proteomic approach","volume":"54","author":"Ooka","year":"2010","journal-title":"Microbiol Immunol"},{"issue":"24","key":"10.1016\/j.autrev.2023.103444_bb0610","article-title":"Continuum: the paraneoplastic disorders","volume":"312","author":"Lancaster","year":"2015","journal-title":"Continuum (N Y)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0615","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2021-326656","article-title":"Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome","volume":"93","author":"Valencia-Sanchez","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0620","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurology(R) Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103444_bb0625","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S213553","article-title":"Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection","volume":"11","author":"Sonoda","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0630","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00000658-197201000-00008","article-title":"Pelvic exenteration for late second cancers of the uterne cervic after earlier irradiation","volume":"175","author":"Deckers","year":"1972","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.autrev.2023.103444_bb0635","doi-asserted-by":"crossref","DOI":"10.1111\/j.1447-0756.2005.00343.x","article-title":"Late recurrence of invasive cervical cancer: Twenty years\u2019 experience in a single cancer institute","volume":"31","author":"Goto","year":"2005","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0640","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(20000715)89:2<255::AID-CNCR8>3.0.CO;2-N","article-title":"Early and late recurrence after gastrectomy for gastric carcinoma: univariate and multivariate analyses","volume":"89","author":"Shiraishi","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0645","article-title":"Late recurrence of gastric cancer in the ovary and uterine cervix","volume":"5","author":"Watanabe","year":"2016","journal-title":"Int Cancer Conf J"},{"key":"10.1016\/j.autrev.2023.103444_bb0650","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.8083","article-title":"A case of late recurrence of colon cancer after curative treatment","author":"Al Hillan","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0655","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.8006","article-title":"Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer","volume":"2","author":"Kishan","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.autrev.2023.103444_bb0660","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djab202","article-title":"The incidence of breast cancer recurrence 10-32 years after primary diagnosis","volume":"114","author":"Pedersen","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0665","doi-asserted-by":"crossref","DOI":"10.12788\/cutis.0618","article-title":"Ultra-late cutaneous melanoma recurrence following 49 years of quiescence","volume":"110","author":"Sax","year":"2022","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0670","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16106","article-title":"Late recurrence of melanoma after 10 years \u2013 Is the course of the disease different from early recurrences?","volume":"34","author":"Sarac","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0675","doi-asserted-by":"crossref","DOI":"10.1089\/jayao.2021.0221","article-title":"Ultra-late osteosarcoma recurrences: an analysis of 17 cooperative osteosarcoma study group patients with a first recurrence detected more than 10 years after primary tumor diagnosis","volume":"12","author":"Hecker-Nolting","year":"2023","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"29","key":"10.1016\/j.autrev.2023.103444_bb0680","article-title":"Very late relapse of high-grade osteosarcoma: a case report and review of the literature","volume":"99","author":"Kaneuchi","year":"2020","journal-title":"Medicine (United States)"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0685","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18180","article-title":"Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma \u2013 A study from the Danish Lymphoma Registry","volume":"198","author":"Andersen","year":"2022","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.autrev.2023.103444_bb0690","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.0807-18","article-title":"Very late relapse of acute promyelocytic leukemia 17 years after continuous remission","volume":"57","author":"Sakurai","year":"2018","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2023.103444_bb0695","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.leukres.2010.09.016","article-title":"Very late recurrences of leukemia: Why does leukemia awake after many years of dormancy?","volume":"35","author":"Norkin","year":"2011","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0700","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-022-10075-x","article-title":"Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors","volume":"42","author":"Heidrich","year":"2023","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"issue":"APR","key":"10.1016\/j.autrev.2023.103444_bb0710","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0715","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2133.1998.02168.x","article-title":"Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease","volume":"138","author":"Setterfield","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103444_bb0720","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0725","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2023.103444_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.07.039","article-title":"NELL1 is a target antigen in malignancy-associated membranous nephropathy","volume":"99","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.autrev.2023.103444_bb0735","doi-asserted-by":"crossref","DOI":"10.1053\/j.ackd.2013.08.003","article-title":"Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation","volume":"21","author":"Jhaveri","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"10.1016\/j.autrev.2023.103444_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102987","article-title":"Cancer incidence in primary Sj\u00f6gren\u2019s syndrome: data from the French hospitalization database","volume":"20","author":"Goulabchand","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2023.103444_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102633","article-title":"Association between systemic sclerosis and risk of lung cancer: results from a pool of cohort studies and Mendelian randomization analysis","volume":"19","author":"Peng","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2023.103444_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2012.02.021","article-title":"Malignancies associated with systemic sclerosis","volume":"11","author":"Szekanecz","year":"2012","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:00Z","timestamp":1761600420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":150,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1568997223001787"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103444","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103444"}}